Invasive NSTEMI Strategy Shows No Benefit in Frail Patients - Top-Institutions - MDSpire

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

Frailty severity may identify older patients least likely to benefit—and potentially at higher risk—with invasive management.

  • By

  • Kathryn Wighton

  • May 6, 2026

  • 4 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University
    Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University

    Newcastle, England

    Key Differentiators

    • Cardiology

  • #2

    Vall d'Hebron University Hospital
    Vall d'Hebron University Hospital

    Barcelona, Spain

    Key Differentiators

    • Cardiology

  • #3

    Heart Centre of the University Hospital of Cologne
    Heart Centre of the University Hospital of Cologne

    Cologne, Germany

    Key Differentiators

    • Cardiology

Original Source(s)

Invasive NSTEMI Strategy Shows No Benefit in Frail Patients

  • by Kathryn Wighton

  • May 6, 2026

Related Content

Elevated angiography-derived microvascular resistance and HbA1c levels jointly predict adverse outcomes in patients with diabetic STEMI: a multicenter retrospective cohort study

Case Report: A case of a giant right ventricular wall hematoma caused by coronary artery perforation during percutaneous coronary intervention

Differentiating Ischemic From Nonischemic T-Wave Inversion Using a Multimodal Vision-Language Model With Reinforcement Learning (ECG-R1): Development and Validation Study